Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tangshan Hongxing Pharmaceutical is a Chinese pharmaceutical company based in Tangshan, Hebei Province, specializing in the development and manufacture of Traditional Chinese Medicines (TCM) and chemical drugs. Established in 1970, the company has built a robust portfolio of products including tablets, capsules, and granules that address various health needs in pediatrics, cardiology, and gastroenterology. Its flagship products, such as Xiaoer Xiaoshi Pian, are well-recognized in the domestic market for treating digestive issues in children. The company operates under strict Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its medicinal offerings. Tangshan Hongxing Pharmaceutical remains a key player in the regional pharmaceutical industry, serving both prescription and over-the-counter markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tangshan Hongxing Pharmaceutical.